MXPA02004701A - Sales de hidroxieicosatetraenoato, composiciones y metodos de uso para tratar trastornos de resequedad en los ojos. - Google Patents

Sales de hidroxieicosatetraenoato, composiciones y metodos de uso para tratar trastornos de resequedad en los ojos.

Info

Publication number
MXPA02004701A
MXPA02004701A MXPA02004701A MXPA02004701A MXPA02004701A MX PA02004701 A MXPA02004701 A MX PA02004701A MX PA02004701 A MXPA02004701 A MX PA02004701A MX PA02004701 A MXPA02004701 A MX PA02004701A MX PA02004701 A MXPA02004701 A MX PA02004701A
Authority
MX
Mexico
Prior art keywords
compositions
salts
methods
dry eye
hydroxyeicosatetraenoate
Prior art date
Application number
MXPA02004701A
Other languages
English (en)
Inventor
Pasquine Terri
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Inc filed Critical Alcon Inc
Publication of MXPA02004701A publication Critical patent/MXPA02004701A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/42—Separation; Purification; Stabilisation; Use of additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Se muestran sales de HETE, la preparacion de las sales de HETE, la preparacion de composiciones de HETE estables y eficaces, composiciones de HETE y metodos de uso para el tratamiento de la resequedad en los ojos.
MXPA02004701A 1999-11-09 2000-10-23 Sales de hidroxieicosatetraenoato, composiciones y metodos de uso para tratar trastornos de resequedad en los ojos. MXPA02004701A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US16438299P 1999-11-09 1999-11-09
US16438499P 1999-11-09 1999-11-09
US16437099P 1999-11-09 1999-11-09
US0039227 2000-10-23

Publications (1)

Publication Number Publication Date
MXPA02004701A true MXPA02004701A (es) 2004-09-10

Family

ID=27389012

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02004701A MXPA02004701A (es) 1999-11-09 2000-10-23 Sales de hidroxieicosatetraenoato, composiciones y metodos de uso para tratar trastornos de resequedad en los ojos.

Country Status (20)

Country Link
US (1) US6429227B1 (es)
EP (1) EP1228028B1 (es)
JP (1) JP2003513949A (es)
KR (1) KR20020050240A (es)
CN (1) CN1387503A (es)
AR (1) AR032607A1 (es)
AT (1) ATE301630T1 (es)
AU (1) AU776187B2 (es)
BR (1) BR0015436A (es)
CA (1) CA2388044A1 (es)
DE (1) DE60021908T2 (es)
DK (1) DK1228028T3 (es)
ES (1) ES2242643T3 (es)
HK (1) HK1045302B (es)
MX (1) MXPA02004701A (es)
PL (1) PL356093A1 (es)
PT (1) PT1228028E (es)
TR (1) TR200201250T2 (es)
TW (1) TWI283176B (es)
WO (1) WO2001034549A1 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002224337A1 (en) * 2000-10-23 2002-05-06 Alcon, Inc. Use of hydroperoxyeicosatetraenoic acid derivatives following refractive surgery
US20030109508A1 (en) * 2001-10-11 2003-06-12 Alcon, Inc. Methods for treating dry eye
WO2003030892A1 (en) * 2001-10-11 2003-04-17 Alcon, Inc. Methods for treating dry eye
EP1583527A1 (en) 2002-06-14 2005-10-12 Alcon, Inc. Use of hydroxyeicosatetraenoic acid compounds to treat ophthalmic inflammatory disorders
US20030236284A1 (en) * 2002-06-14 2003-12-25 Alcon, Inc. Use of hydroxyeicosatetraenoic acid compounds to treat vaginal dryness
US20040002514A1 (en) * 2002-06-14 2004-01-01 Alcon, Inc. Topical use of hydroxyeicosatetraenoic acid compounds to treat psoriasis
AU2003235452A1 (en) * 2002-06-14 2003-12-31 Alcon, Inc. Use of hydroxyeicosatetraenoic acid compounds to treat dry mouth
EP1542768A1 (en) * 2002-09-20 2005-06-22 Alcon, Inc. Use of cytokine synthesis inhibitors for the treatment of dry eye disorders
PT1551417E (pt) * 2002-10-18 2008-10-31 Aqueous Pharma Ltd Formulação de lágrimas com três camadas
US20050187192A1 (en) * 2004-02-20 2005-08-25 Kucera Pharmaceutical Company Phospholipids for the treatment of infection by togaviruses, herpes viruses and coronaviruses
WO2005094322A2 (en) 2004-03-29 2005-10-13 University Of South Florida Effective treatment of tumors and cancer with triciribine and related compounds
KR100642425B1 (ko) * 2004-07-09 2006-11-03 (유) 이도건설 친수호안 구조
EP1793836A4 (en) * 2004-10-01 2008-09-03 Richard L Lindstrom OPHTHALMIC COMPOSITIONS WITH LUBRICANTS, DETERMINANTS AND GLYCOSAMINOGLYCAN AND METHOD FOR THEIR USE
US7638142B2 (en) * 2005-10-12 2009-12-29 Vitamin Science, Inc. Therapeutic composition for the treatment of dry eye syndrome
WO2010064636A1 (ja) * 2008-12-02 2010-06-10 ロート製薬株式会社 眼科用組成物
GB0907413D0 (en) 2009-04-29 2009-06-10 Equateq Ltd Novel methods
TR201807857T4 (tr) * 2011-01-26 2018-06-21 Allergan Inc Oftalmik bir durumun tedavi edilmesine yönelik androjen bileşimi.
IL212725A (en) * 2011-05-05 2016-06-30 Resdevco Res And Dev Co Glycerol Preparation for Non-surgical Conjunctivochalysis
HUE052793T2 (hu) * 2013-02-01 2021-05-28 Allergan Inc Nátrium-hialuronátot és karboximetil-cellulózt tartalmazó mûkönny
EP3068757B1 (en) * 2013-11-15 2019-02-27 DS Biopharma Limited Lysine salt of 15-hydroxy-8(z),11(z),13(e)-eicosatrienoic acid

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3991759A (en) 1975-10-28 1976-11-16 Alza Corporation Method and therapeutic system for treating aqueous deficient dry eye
US4131651A (en) 1977-10-25 1978-12-26 Barnes-Hind Pharmaceuticals, Inc. Treatment of dry eye
US4409205A (en) 1979-03-05 1983-10-11 Cooper Laboratories, Inc. Ophthalmic solution
US4370325A (en) 1979-03-30 1983-01-25 Dermik Laboratories Pharmaceutical compositions and method of treatment
AU546872B2 (en) 1982-06-16 1985-09-26 Unilever Plc Skin treatment compositions containing a fatty acid or ester
US4421748A (en) 1982-07-13 1983-12-20 Trager Seymour F Artificial tear aid
GB8319073D0 (en) 1983-07-14 1983-08-17 Efamol Ltd Fatty acid compositions
US4868154A (en) 1986-02-19 1989-09-19 Eye Research Institute Of Retina Foundation Stimulation of tear secretion with melanocyte stimulating hormones
US4753945A (en) 1986-02-19 1988-06-28 Eye Research Institute Of Retina Foundation Stimulation of tear secretion with phosphodiesterase inhibitors
US4744980A (en) 1986-04-28 1988-05-17 Holly Frank J Ophthalmic solution for treatment of dry eye syndrome
US4883658A (en) 1986-04-28 1989-11-28 Holly Frank J Ophthalmic solution for treatment of dry-eye syndrome
US4818537A (en) 1986-10-21 1989-04-04 Liposome Technology, Inc. Liposome composition for treating dry eye
US4966773A (en) 1986-11-25 1990-10-30 Alcon Laboratories, Inc. Topical ophthalmic compositions containing microfine retinoid particles
US5278151A (en) 1987-04-02 1994-01-11 Ocular Research Of Boston, Inc. Dry eye treatment solution
US4914088A (en) 1987-04-02 1990-04-03 Thomas Glonek Dry eye treatment solution and method
US4921644A (en) 1988-02-29 1990-05-01 Technology Unlimited, Inc. Mucin directed lipsome
US4906467A (en) 1988-03-24 1990-03-06 New York Medical College Novel, long-duration treatment for glaucoma
US4923700A (en) 1988-06-03 1990-05-08 Kaufman Herbert E Artificial tear suspension
US5064655A (en) 1989-02-24 1991-11-12 Liposome Technology, Inc. Liposome gel composition and method
US5075104A (en) 1989-03-31 1991-12-24 Alcon Laboratories, Inc. Ophthalmic carboxy vinyl polymer gel for dry eye syndrome
US5174988A (en) 1989-07-27 1992-12-29 Scientific Development & Research, Inc. Phospholipid delivery system
WO1991012808A1 (en) 1990-02-22 1991-09-05 Macnaught Pty Limited Artificial tears
US5041434A (en) 1991-08-17 1991-08-20 Virginia Lubkin Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and application
ZA912797B (en) 1990-05-29 1992-12-30 Boston Ocular Res Dry eye treatment process and solution
ES2084722T3 (es) 1990-05-29 1996-05-16 Boston Ocular Res Composicion para tratamiento del ojo seco.
US5102670A (en) 1990-09-14 1992-04-07 Abraham Nader G Method for treating eye disorders by reducing 12(r)-hydroxyeicosatetraenoic acid and 12(r)-dihydroxyeicosatrienoic acid levels
ATE141502T1 (de) 1991-01-15 1996-09-15 Alcon Lab Inc Verwendung von karrageenan in topischen ophthalmologischen zusammensetzungen
ZA927277B (en) 1991-10-02 1993-05-19 Boston Ocular Res Dry eye treatment process and solution.
EP0546728A3 (en) 1991-12-13 1993-09-08 Alcon Laboratories Inc Physiological tear compositions and methods for their preparation
JPH07508716A (ja) 1992-04-21 1995-09-28 ザ　スキーペンズ　アイ　リサーチ　インスティテュート，インコーポレイテッド シェーグレン症候群における眼のアンドロゲン療法
US5290572A (en) 1992-08-06 1994-03-01 Deo Corporation Opthalmic composition for treating dry eye
US5358706A (en) 1992-09-30 1994-10-25 Union Carbide Chemicals & Plastics Technology Corporation Muco-adhesive polymers
US5455265A (en) 1993-02-11 1995-10-03 Allergan, Inc. Method of treatment with compounds having selective agonist-like activity on RXR retinoid receptors
US5389383A (en) 1993-06-18 1995-02-14 Allergan, Inc. Method for treating hypoxia-associated ocular complications
US5696166A (en) * 1995-10-31 1997-12-09 Yanni; John M. Compositions containing hydroxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders
NZ336539A (en) 1996-10-15 2000-09-29 Liposome Co Inc Peptide-lipid conjugates, liposomes and liposomal drug delivery
US5800807A (en) 1997-01-29 1998-09-01 Bausch & Lomb Incorporated Ophthalmic compositions including glycerin and propylene glycol
JP2002538124A (ja) 1999-03-01 2002-11-12 ヴィスタ サイエンティフィック エルエルシー ムチンを含む眼科用調合物

Also Published As

Publication number Publication date
ES2242643T3 (es) 2005-11-16
TWI283176B (en) 2007-07-01
KR20020050240A (ko) 2002-06-26
HK1045302B (zh) 2005-10-14
PT1228028E (pt) 2005-10-31
JP2003513949A (ja) 2003-04-15
DE60021908D1 (de) 2005-09-15
AU776187B2 (en) 2004-09-02
EP1228028B1 (en) 2005-08-10
TR200201250T2 (tr) 2002-09-23
DE60021908T2 (de) 2006-04-06
US6429227B1 (en) 2002-08-06
DK1228028T3 (da) 2005-11-14
CN1387503A (zh) 2002-12-25
HK1045302A1 (en) 2002-11-22
AR032607A1 (es) 2003-11-19
BR0015436A (pt) 2002-07-16
PL356093A1 (en) 2004-06-14
AU1101401A (en) 2001-06-06
CA2388044A1 (en) 2001-05-17
EP1228028A1 (en) 2002-08-07
WO2001034549A1 (en) 2001-05-17
ATE301630T1 (de) 2005-08-15

Similar Documents

Publication Publication Date Title
MXPA02004701A (es) Sales de hidroxieicosatetraenoato, composiciones y metodos de uso para tratar trastornos de resequedad en los ojos.
TR200002773T2 (tr) Alzheimer tedavisi için smilagenin ve anzurogenin-D ve bunların kullanımı.
MXPA00007388A (es) Metodos para tratar la pigmentacion de la piel.
BG64475B1 (bg) Ципразидонови соли
AU2592600A (en) Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
MXPA03005893A (es) Proteccion, restauracion, y mejora de celulas, tejidos y organos que responden a la eritropoyetina.
NZ508808A (en) 4-benzyl piperidine alkylsulfoxide heterocycles and their use as subtype-selective NMDA receptor antagonists
SI1525177T1 (sl) Substituirani 1,3-difenilprop-2-en-1-on derivati,priprava in njihova uporaba
AU2001253038A1 (en) Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
TR200100054T2 (tr) Paroksetin metansülfonat
BR9814923A (pt) Método para tratamento de doença de alzheimer
HK1050860A1 (en) Nordihydroguaiaretic derivatives for use in treatment of tumors
HK1045986A1 (en) Compositions containing hydroxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders.
BR0015392A (pt) Lipoxina a4 e seus análogos para o tratamento de olho ressecado
AU2001266152A1 (en) Novel substituted nitrocatechols, their use in the treatment of some central andperipheral nervous system disorders and pharmaceutical compositions containing them
SE9802208D0 (sv) Novel compounds
IT1264530B (it) Impiego dei polisaccaridi nelle neuropatie atrofico degenerative
MXPA02010957A (es) Composicion reductora para el tratamiento de las fibras queratinicas que comprende una silicona aminada particular.
EE05211B1 (et) Saredutandi ja selle farmatseutiliselt vastuv?etavate soolade kasutamine meeleoluh„irete, kohanemish„irete v?i segatpi „rev-depressiivsete h„irete raviks v?i v„ltimiseks kasulike ravimite valmistamiseks
SE9802209D0 (sv) Novel compounds
DK1292263T3 (da) Vitamin B6-derivater som plejekomponenter i den oxidative hårbehandling
MXPA02004702A (es) Analogos interrumpidos por heteroatomos de acido 15-hidroxieicosatetraenoico y metodos de uso.
MY127675A (en) Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods
AU2002226060A1 (en) Compositions containing gangliosides for use in the treatment of skin disorders
NO20006699D0 (no) Forbindelser med veksthormonfrigjörende egenskaper

Legal Events

Date Code Title Description
FG Grant or registration